In 2015, a 7.8 earthquake hit Nepal, killing nearly 9,000 and injuring thousands. The earthquake resulted in losses exceeding ...

UT researchers have created an alternative to Edman degradation for protein sequencing using bases instead of acid ...

This week, dual escalations in Yemen and Ukraine raises sharp questions about America’s strategic priorities and its ability ...

Moffitt Cancer Center launches new podcast, The ImmunoVerse, where Patrick Hwu, MD, will discuss immunotherapy research with ...

A biotech firm based in Milton Park, Oxfordshire, has received a major boost after its T-cell therapy was awarded Breakthrough Therapy Designation by the US Food and Drug Administration, ...

Scientists developed a machine-learning tool that can teach itself, with minimal external guidance, to differentiate between ...

NurExone's ExoTherapy platform enables precise, minimally-invasive delivery of therapies to injured tissues using exosomes as an advanced delivery system. With a growing body of preclinical data and ...

A new study forecasts more than 850,000 measles cases over the next 25 years if US vaccination rates stay the same. Millions ...

Colossal Biosciences' claim to have achieved the 'de-extinction' of the dire wolf has been questioned by geneticists, but the ...

Portland-based biotech company Araceli Biosciences raised $11.2 million in new funding to fuel the expansion of its ...

In his concluding remarks, Dr. Jitendra Singh reflected on the future of India’s economy, which he asserted would be ...

Morgan Cheatham, a physician-informaticist and former Bessemer VC, joins Breyer Capital to lead healthcare and life sciences ...